Glucose, urea, and creatinine laboratory tests in people starting antiretroviral therapy with dolutegravir or efavirenz: a cohort study in Belo Horizonte, Brazil. Research, Society and Development, [S. l.], v. 11, n. 5, p. e43711528541, 2022. DOI: 10.33448/rsd-v11i5.28541. Disponível em: https://www.rsdjournal.org/rsd/article/view/28541. Acesso em: 15 dec. 2025.